Analysts name 4 reporting season disappointments: Do you own these laggards?

Lynas Corporation Limited (ASX:LYC) and Tatts Group Limited (ASX:TTS) lead a list of disappointing stocks this earnings season

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A review of analysts' recommendations by Bloomberg identified a surprising list of companies that have earned the ire of Australia's top analysts due to either disappointing results or a lacklustre outlook for 2015. As upgrades and downgrades are made to price forecasts it's worth considering which stocks may be re-rated.

Consumer discretionary stocks were hit hard in the lead up to reporting season in June and July, but it's a motley group of companies that have suffered analyst downgrades this month.

Four Disappointments

The following four companies appear to have one factor in common; analysts are not convinced about the outlook for sales and profit growth in 2015.

Lynas Corporation Limited (ASX: LYC) revealed another disappointing set of results that has analysts and investors expecting yet another capital raising in the near future. The rare earths market has had another tough year and Lynas' ramp up to full production isn't yet producing enough cash to cover costs. Speculators moving in and out of Lynas' stock have no doubt made more money than long-term investors in this perennial disappointment.

Orora Ltd (ASX: ORA) reported a 44% increase in net profit for the year to June 30, however analysts are a little concerned that the group hasn't made as many acquisitions as expected and thus growth may be slower in the next 12 months.

Similarly, Pact Group Holdings Ltd (ASX: PGH) beat profit expectations but investors were disappointed at the outlook for negligible growth in 2015 unless acquisitions are made. Companies relying on domestic consumption appear to be struggling at the moment.

Finally, Tatts Group Limited (ASX: TTS) reported a 19% fall in net profit and 15% fall in dividend payout, well below expectations. Analysts are questioning whether Tatts should remain on such a high price to earnings ratio seeing as earnings from the company's defensive lotteries division (accounting for 60% of earnings) grew less than 1% for the year.

Motley Fool contributor Andrew Mudie does not own shares in any companies mentioned. You can find Andrew on Twitter @andrewmudie

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »